One Nucleus Signs Agreement with Venture Valuation to enable dealflow
Enabling member-to-member and member-to-non-member deal flow is a key driver for One Nucleus and the main reason so many companies join the largest life science membership organisation in Europe. A key facilitator of these benefits is the ability for visitors to our website to be able to identify suitable technology partners and customers in a timely manner. Tony Jones, Director of Business Development at One Nucleus commented ‘the ability for visitors to identify One Nucleus member companies through routes other than One Nucleus is extremely beneficial.
Biotechgate, administered by Venture Valuation, is one of the largest life science company databases globally, supporting EBD Group events such as BIOEurope and numerous leading life science cluster organisations such as BIOCOM, BIOTECanada and Medicon Valley (MVA) in enabling their members and clients to search for suitable business partners. Patrik Frei, CEO of Venture Valuation stated, ‘we are very happy to welcome One Nucleus, one of the key life sciences networks in Europe, as one of over 30 partners worldwide.’
About One Nucleus
Established in May 2010, One Nucleus is the result of the merger of ERBI and London Biotechnology Network. One Nucleus is a not-for-profit membership organisation for international life science and healthcare companies and the largest of its kind in Europe. The company is based in Cambridge UK and London, at the heart of Europe's largest cluster. The 450 members include pharmaceutical, biotech, medical device and diagnostic companies and associated technical and commercial Service Providers.
In 2004, based on the requirement to have access to accurate and up-to-date industry intelligence, Venture Valuation implemented the Swiss Life Sciences Database. Information in this database, and subsequently created country portals, is encompassed in Biotechgate, the comprehensive, global Life Sciences database.
Using a bottom-up approach and partnering with local networks, associations and economic development agencies, Venture Valuation catalogues and categorises Life Sciences firms including Biotech, Pharma and Medtech companies, as well as associated suppliers, consultancies, investors, and non-profit organisations. Company profiles contain contact information, descriptions, details of products and/or services, and information regarding finance and management. Currently the database contains over 20,000 company profiles, 20,000 products and 25,000 management details.
Tel: +44 (0) 1223 896 450
Tel: +41 43 321 8660
Venture Valuation specialises in independent assessment and valuation of technology-driven companies in growth industries, mainly in Life Sciences (Biotech, Pharma, Medtech. In addition to valuation products, Venture Valuation offers high-quality, focused information services. Through their focus and unique position, they strive to fulfil and surpass customer needs and add value to the partnership.
Venture Valuation AG
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release One Nucleus Signs Agreement with Venture Valuation to enable dealflow here
News-ID: 166360 • Views: 1683
More Releases for Nucleus
Digital Lending Platform Market Is Booming Worldwide | Fiserv, Newgen Software, …
Global Digital Lending Platform Market Size, Status and Forecast 2020-2026 , Covid 19 Outbreak Impact research report added by Report Ocean, predicts the industry’s performance for the upcoming years to help stakeholders in making the right decisions that can potentially garner strong returns. Further, the document provides comprehensive analysis of the key industry trends as well as the opportunities that will ensure an upward growth trajectory in the coming
BPMonline Is in the Latest Nucleus Research CRM Value Matrix
BPMonline, a global provider of CRM and BPM solutions, has been recognized in the recently released Nucleus Research CRM Value Matrix for the second half of 2013. Nucleus Research, a leading global information technology research firm, is specializing in investigative research of technology deployments. The Matrix reflects current positioning as well as an estimate of the trendline based on Nucleus’s current view of products and roadmaps. The Value Matrix is based
PAS-X Information Nucleus at B. Braun Irvine
PAS-X Information Nucleus at B. Braun Irvine US site implements sophisticated multi-level IT architecture with Werum’s PAS-X Lueneburg, Germany, 12 June 2012 – B. Braun’s facility in Irvine, CA is currently installing a new, highly automated production line, with Werum’s PAS-X as a core component. The line, designed to produce a variety of IV Solution bags for hospitals and clinics, will manufacture the empty bags, fill them, sterilize them, and package them,
Nucleus Technologies.Com enters into Password recovery
Nucleus Technologies.com, the industry leader in providing data recovery software and services announced the release of Kernel VBA Password recovery software. The company has recently entered the arena of password recovery software(s) and this software is fifth in a row. New Delhi, July 14, 2006 – Nucleus Technologies.com, the industry leader in providing data recovery software and services announced the launch of Kernel VBA Password recovery software. Kernel for VBA password
The launch of Nucleus Kernel for DBF
Nucleus Technologies.com – provider of successful data recovery products and services released Kernel for DBF database recovery software for the corrupt .dbf files. New Delhi July 14, 2006 - Nucleus Technologies.com, the world class leader in providing data recovery software and services today announced the release of Kernel for DBF software – a powerful tool that recovers damaged DBF files. Kernel for DBF is database recovery software which repairs the corrupted